NORTH READING, Mass., Nov. 16, 2016 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for
Company growth highlights for third quarter of 2016 include:
"Our continuous company performance and success is a strong indicator that the industry is beginning to recognize the urgency of serialization and that a proven solution with an end-to-end network model is the only way to ensure drug supply and safety," said Shabbir Dahod, president and CEO of TraceLink. "As compliance deadlines get closer, we've seen an increasing trend of companies who have previously selected other solution providers promising DSCSA solutions but abandon those decisions after recognizing that TraceLink is the only proven solution available with live serialization customers. While many providers are still focusing on implementation, TraceLink maintains a long-term vision on track and trace and has developed industry performance benchmarks in serialization that demonstrate speed, scalability and the ability to efficiently exchange data with trade partners on the Life Sciences Cloud."
Additional highlights include:
About TraceLinkTraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses, including 16 of the top-20 global pharmaceutical companies, trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 293 in 2015), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by FirstMark Capital, Volition Capital and F-Prime Capital.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tracelink-reports-annual-bookings-growth-of-112-for-q3-2016-300363526.html
SOURCE TraceLink Inc.
Subscribe to our Free Newsletters!
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...
A prosthetic heart valve is an artificial device surgically implanted into the heart to replace a ...View All